FPI Cobra India (Mauritius) sells 2.05% stake in Sakar Healthcare

Fii Holding DeclinedOwnership Changes View source PDF Explain this filing

SAKAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹807.00

prior close

₹814.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+0.6% vs market

Pharmaceuticals peers, median of 167sector+0.4%+1.6% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.0

15m

-0.7

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0+1.4+0.6+0.4+1.6

Next day

+6.8+1.5+5.3+0.7+6.1

+14.0+0.5+13.5+0.4+13.6

+14.0+1.1+12.9+0.6+13.4

+10.8+0.7+10.1+0.4+10.4

+8.5-0.4+8.9-0.7+9.3

+9.4+0.5+8.9+0.2+9.2

15d

+9.9+0.1+9.8-2.0+12.0

+12.8+3.5+9.2-0.7+13.5

+38.8+5.8+33.0+1.8+36.9

+22.7+2.4+20.3-1.7+24.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cobra India (Mauritius), an FPI and not a promoter, sold 489,026 shares (2.05%) of Sakar Healthcare via open market on 11 June 2026. Its holding fell from 14.70 lakh shares (6.45%) to 9.81 lakh shares (4.41%). The disclosure was filed under SEBI Takeover Regulations due to the change of more than 2% in shareholding, crossing below the 5% threshold.

Likely market impact

FPI selling signals reduced foreign interest in the stock. May add short-term pressure on price; foreign holding now below 5%.